(Q38075430)

28 August 2017

1 reference

title

Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis (English)

1 reference

28 August 2017

0 references

1 reference

1 reference

pulmonary hypertension

1 reference

Anupama Shahane

1

1 reference

PubMed ID

23334373

28 August 2017

language of work or name

1 reference

19 January 2013

1 reference

Rheumatology International

28 August 2017

1 reference

28 August 2017

33

1 reference

28 August 2017

7

1 reference

28 August 2017

1655-1667

1 reference

https://scigraph.springernature.com/pub.10.1007/s00296-012-2659-y

28 August 2017

0 references

cites work

Current therapeutics and practical management strategies for pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Pulmonary arterial hypertension and rheumatic diseases--from diagnosis to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Clinical differences between idiopathic and scleroderma-related pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Changes in causes of death in systemic sclerosis, 1972-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Pulmonary arterial hypertension in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Autoantibody to U3 Nucleolar Ribonucleoprotein (Fibrillarin) In Patients with Systemic Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Is pulmonary arterial hypertension really a late complication of systemic sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Pulmonary arterial hypertension complicating connective tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

The pulmonary pathologic manifestations of the CREST syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Plasma endothelin-1 levels in patients with systemic sclerosis: influence of pulmonary or systemic arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

A case of pulmonary veno‐occlusive disease associated with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Treatment of pulmonary hypertension secondary to connective tissue diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Pulmonary hypertension in autoimmune rheumatic diseases: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Endothelin-1 release from cultured endothelial cells induced by sera from patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Pulmonary vascular manifestations of mixed connective tissue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

The prognosis of mixed connective tissue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Cardiovascular manifestations of mixed connective tissue disease in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Primary Sjogren's syndrome in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Lung function in primary Sjögren's syndrome: a cross sectional and longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Anti-RNP immunity: implications for tissue injury and the pathogenesis of connective tissue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Pulmonary hypertension and granulomatous vasculitis in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Pulmonary hypertension in dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Exercise limitation in patients with polymyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Isolated pulmonary hypertension secondary to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Long-term clinical course of a patient with anti PL-12 antibody accompanied by interstitial pneumonia and severe pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Acute pulmonary arterial hypertension associated with anti-synthetase syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Connective tissue associated pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Pulmonary hypertension associated with connective tissue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Lung transplantation in patients with scleroderma: case series, review of the literature, and criteria for transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Outcomes of lung transplantation in patients with scleroderma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Imatinib mesylate for the treatment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2659-Y

Age and risk of pulmonary arterial hypertension in scleroderma

21 January 2018

1 reference

12 December 2020

Asymptomatic pulmonary hypertension in systemic lupus erythematosus

1 reference

12 December 2020

Pulmonary hypertension in connective tissue disease. Clinical analysis of sixty patients in multi-institutional study

1 reference

12 December 2020

Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein

1 reference

12 December 2020

Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis

1 reference

12 December 2020

Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension

1 reference

12 December 2020

Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus

1 reference

12 December 2020

Pulmonary hypertension in polymyositis

1 reference

12 December 2020

Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis

1 reference

12 December 2020

Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients

1 reference

12 December 2020

Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases

1 reference

12 December 2020

Pulmonary hypertension in systemic lupus erythematosus: A case report

1 reference

12 December 2020

Pulmonary hypertension in rheumatoid arthritis--relation with the duration of the disease

1 reference

12 December 2020

Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.

1 reference

12 December 2020

Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1

1 reference

12 December 2020

Pulmonary hypertension and systemic lupus erythematosus.

1 reference

12 December 2020

[Pulmonary hypertension associated with systemic lupus erythematosus]

1 reference

12 December 2020

Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis

1 reference

12 December 2020

Treating pulmonary arterial hypertension: cautious hope in a deadly disease

1 reference

12 December 2020

Pulmonary manifestations of Sjögren's syndrome

1 reference

12 December 2020

Respiratory manifestations in primary Sjögren's syndrome. A clinical, functional, and histologic study

1 reference

12 December 2020

Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension

1 reference

12 December 2020

Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus

1 reference

12 December 2020

Pulmonary hypertension in polymyositis-dermatomyositis: clinical and hemodynamic characteristics and response to vasoactive therapy

1 reference

12 December 2020

Pulmonary hypertension in a lupus clinic: experience with twenty-four patients

1 reference

12 December 2020

Pulmonary veno-occlusive disease and the CREST variant of scleroderma

1 reference

12 December 2020

Guidelines for the diagnosis and treatment of pulmonary hypertension.

1 reference

12 December 2020

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

1 reference

12 December 2020

Pulmonary arterial histology and morphometry in systemic sclerosis: a case-control autopsy study

1 reference

12 December 2020

Pulmonary hypertension in systemic sclerosis

1 reference

12 December 2020

Pulmonary and cardiac manifestations of polymyositis-dermatomyositis

1 reference

12 December 2020

A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease.

1 reference

12 December 2020

Severe, reversible pulmonary hypertension in a patient with monoclonal gammopathy and features of dermatomyositis

1 reference

12 December 2020

Noninvasive assessment of systolic pulmonary artery pressure in systemic lupus erythematosus: retrospective analysis of 93 patients

1 reference

12 December 2020

Immunological studies in 'primary' idiopathic pulmonary hypertension

1 reference

12 December 2020

Severe pulmonary hypertension in Anti-Jo-1 syndrome

1 reference

12 December 2020

Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients

1 reference

12 December 2020

Pulmonary hypertension in a case of dermatomyositis

1 reference

12 December 2020

Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy

1 reference

12 December 2020

Precapillary pulmonary hypertension dramatically improved with high doses of corticosteroids during systemic lupus erythematosus

1 reference

12 December 2020

Immunosuppressive Therapy in Connective Tissue Diseases-Associated Pulmonary Arterial Hypertension

1 reference

12 December 2020

Pulmonary arterial hypertension in ANCA-associated vasculitis

1 reference

12 December 2020

Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era

1 reference

12 December 2020

Pulmonary hypertension in systemic lupus erythematosus

1 reference

12 December 2020

10.1007/S00296-012-2659-Y

Identifiers

DOI

1 reference

PubMed ID

23334373

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23334373